
Schrödinger - Physics-based Software Platform for Molecular …
Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research.
Pipeline of Collaborative & Proprietary Drug Discovery Programs ...
We are leveraging our computational platform and massive computing power to advance our proprietary programs both independently and in collaboration with leading biotech and …
About us - Schrödinger
Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.
Computational Platform for Molecular Discovery & Design
Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space.
Schrödinger, Inc. - Investor Relations
Nov 6, 2025 · Schrödinger is transforming the way therapeutics and materials are discovered. Learn more about our company.
Our Team - Schrödinger
Schrödinger’s collaborative leadership team is committed to achieving the best possible outcomes for our customers, partners, patients, and other stakeholders.
Career Opportunities - Schrödinger
Headquartered in New York City, Schrödinger has multiple offices around the world including the USA, the UK, Germany, India, and Japan.
Explore our latest software - Schrödinger
What’s new in Schrödinger Suite Release? We release new platform usability and technological improvements quarterly.
Office Locations & Local Contact Information - Schrödinger
Schrödinger is a global company with a collaborative spirit. View our office locations and local contact information below.
Schrödinger Announces Discontinuation of SGR-2921 Program
Aug 14, 2025 · Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being evaluated in …